Aejaz Nasir, MD is board-certified in Anatomic Pathology. He completed his residency in Anatomic Pathology at King Edward Medical University, Lahore, Pakistan with distinction, sub-specialty anatomic pathology at Hammersmith Hospital, London, AP/CP residency at George Washington University and GI & Liver Pathology fellowship led by Charles Parkos and Bob Pascal at Emory. After completing Inter-disciplinary Oncologic Pathology fellowship at Moffitt Cancer Center/USF, he served Moffitt as Faculty in Anatomic Pathology, GI & Neuroendocrine Tumor Program, as Chief Pathologist for Total Cancer Care Project/M2Gen with Timothy J. Yeatman, and led molecular research pathology projects in pancreatic endocrine, colon and breast cancers. Dr. Nasir also served in a technical and scientific leadership role, as Senior Medical Advisor & Surgical Pathology Lead, to integrate advanced oncologic pathology with bi-directional translational molecular oncology biomarker research at Eli Lilly & Co. His main areas of clinical expertise include pathology of GI, liver, neuroendocrine, breast disease and solid tumors, especially neuroendocrine malignancies, on which he co-edited a reference book with Prof. Domenico Coppola. His main research interests include molecular oncology biomarker discovery and validation science and implementation of novel molecular biomarkers in clinical trials and practice. Dr. Nasir has authored more than 140 original scientific articles, reviews, abstracts and book chapters, and has published seven cancer research monographs as series editor (“Cancer Growth & Progression” Series by Springer Nature). Apart from speaking engagements at leading pathology and industry meetings, like American Society of Clinical Pathology, The World Biomarker Congress (Boston) and The World Companion Diagnostic Meeting (Philadelphia), Dr. Nasir has led several advanced training courses in GI and neuroendocrine pathology for residents, fellows and practicing pathologists in the U.S. and abroad.